Is CVE-2017-18228 being actively exploited?

CVE-2017-18228 is not currently listed in the CISA Known Exploited Vulnerabilities (KEV) catalog.

What is the CVSS score for CVE-2017-18228?

CVE-2017-18228 has a CVSS 3.0 base score of 5.4 (MEDIUM).

CVE-2017-18228

MEDIUM · CVSS 5.4EPSS 0.5%EU EUVD

Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.

Key facts

CVSS score: 5.4 (v3.0)
Severity: MEDIUM
CVSS vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE): CWE-79
EPSS score: 0.5% (42th percentile)
In CISA KEV: No
In EU EUVD: Yes (EUVD-2017-9360)
Published: March 12, 2018
NVD last modified: June 17, 2026
Status: Modified

EU Vulnerability Database (EUVD)

This vulnerability is also tracked by ENISA as EUVD-2017-9360 in the EU Vulnerability Database. Last updated in EUVD on September 16, 2024.

View on the EU Vulnerability Database

Affected products

bmc / remedy action request system

Certified products that may be affected

1 FIPS 140 or Common Criteria certified product, from automated matching by sec-certs.org.

BMC Remedy Action Request System with Premium Encryption Security v8.1 - BMC Software, Inc. - Common Criteria 383-4-253 - archived

References

https://communities.bmc.com/thread/164169(Vendor Advisory)

Last updated September 17, 2026 · Source: NVD, CISA KEV, FIRST.org EPSS

Query CVEs from your AI assistant

The CVE/NVD Explorer brain answers CVE questions directly inside Claude, ChatGPT, or any MCP assistant — always up to date, no setup. Add it once and stop pasting advisories into chat.

Add the CVE brain